Summary of Study ST003898

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002439. The data can be accessed directly via it's Project DOI: 10.21228/M8CG2W This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003898
Study TitleGlycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis
Study SummaryLipids are essential components of cancer cells due to their structural and signaling roles and many cancers take up extracellular lipids to meet metabolic demands. How these lipids contribute to cancer growth and progression remains poorly understood. Using functional genetic screens, lipoprotein uptake—the primary mechanism for lipid transport in circulation—is identify as a key determinant of ferroptosis sensitivity in cancer. Lipoprotein supplementation robustly inhibits ferroptosis across numerous cancer types, an effect largely driven by lipoprotein delivery of α-tocopherol. Mechanistically, cancer cells take up lipoproteins through a pathway dependent on sulfated glycosaminoglycans (GAGs) linked to cell-surface proteoglycans. Disrupting GAG biosynthesis or acutely degrading surface GAGs reduces lipoprotein uptake, sensitizes cancer cells to ferroptosis, and impairs tumor growth in mice. Notably, human clear cell renal cell carcinomas (ccRCC), a lipid-rich malignancy, exhibit elevated levels of chondroitin sulfate and increased lipoprotein-derived α-tocopherol compared to normal kidney tissue. Altogether, this work establishes lipoprotein uptake as a critical anti-ferroptotic mechanism in cancer and implicates GAG biosynthesis as a therapeutic target.
Institute
University of Texas Southwestern Medical Center at Dallas
DepartmentChildren's Research Institute
LaboratoryMetabolomics Facility
Last NameCai
First NameFeng
Address6000 Harry Hines Blvd.
Emailfeng.cai@utsouthwestern.edu
Phone2146483056
Submit Date2025-04-24
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-05-08
Release Version1
Feng Cai Feng Cai
https://dx.doi.org/10.21228/M8CG2W
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Sample Information
SA4295389456 (9)VM100_Adjacent Kidney
SA4295399456 (10)VM100_Primary ccRCC
SA4295409456 (11)VM101_Adjacent Kidney
SA4295419456 (12)VM101_Primary ccRCC
SA4295429456 (13)VM102_Adjacent Kidney
SA4295439456 (14)VM102_Primary ccRCC
SA4295449456 (15)VM103_Adjacent Kidney
SA4295459456 (16)VM103_Primary ccRCC
SA4295469456 (17)VM104_Adjacent Kidney
SA4295479456 (18)VM104_Primary ccRCC
SA4295489456 (19)VM105_Adjacent Kidney
SA4295499456 (20)VM105_Primary ccRCC
SA4295509456 (21)VM106_Adjacent Kidney
SA4295519456 (22)VM106_Primary ccRCC
SA4295529456 (23)VM107_Adjacent Kidney
SA4295539456 (24)VM107_Primary ccRCC
SA4295549456 (25)VM108_Adjacent Kidney
SA4295559456 (26)VM108_Primary ccRCC
SA4295569456 (27)VM109_Adjacent Kidney
SA4295579456 (28)VM109_Primary ccRCC
SA4295589456 (29)VM110_Adjacent Kidney
SA4295599456 (30)VM110_Primary ccRCC
SA4295609456 (31)VM111_Adjacent Kidney
SA4295619456 (32)VM111_Primary ccRCC
SA4295629456 (33)VM112_Adjacent Kidney
SA4295639456 (34)VM112_Primary ccRCC
SA429564B4 (1)VM91_Adjacent Kidney
SA429565B4 (2)VM91_Primary ccRCC
SA429566B4 (3)VM92_Adjacent Kidney
SA429567B4 (4)VM92_Primary ccRCC
SA429568B4 (5)VM94_Adjacent Kidney
SA429569B4 (6)VM94_Primary ccRCC
SA4295709456 (1)VM95_Adjacent Kidney
SA4295719456 (2)VM95_Primary ccRCC
SA4295729456 (3)VM96_Adjacent Kidney
SA4295739456 (4)VM96_Primary ccRCC
SA4295749456 (5)VM97_Adjacent Kidney
SA4295759456 (6)VM97_Primary ccRCC
SA4295769456 (7)VM98_Adjacent Kidney
SA4295779456 (8)VM98_Primary ccRCC
Showing results 1 to 40 of 40
  logo